Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study.

MLA

Yu, Wei-Wei, et al. “Simultaneous Integrated Boost Intensity-Modulated Radiotherapy in Esophageal Carcinoma: Early Results of a Phase II Study.” Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al], vol. 190, no. 11, Oct. 2014, pp. 979–86. EBSCOhost, https://doi.org/10.1007/s00066-014-0636-y.

APA

Yu, W.-W., Zhu, Z.-F., Fu, X.-L., Zhao, K.-L., Mao, J.-F., Wu, K.-L., Yang, H.-J., Fan, M., Zhao, S., & Welsh, J. (2014). Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al], 190(11), 979–986. https://doi.org/10.1007/s00066-014-0636-y

Chicago

Yu, Wei-Wei, Zheng-Fei Zhu, Xiao-Long Fu, Kuai-Le Zhao, Jing-Fang Mao, Kai-Liang Wu, Huan-Jun Yang, Min Fan, Sen Zhao, and James Welsh. 2014. “Simultaneous Integrated Boost Intensity-Modulated Radiotherapy in Esophageal Carcinoma: Early Results of a Phase II Study.” Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al] 190 (11): 979–86. doi:10.1007/s00066-014-0636-y.